Literature DB >> 6234034

Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura.

V L Woods, Y Kurata, R R Montgomery, P Tani, D Mason, E H Oh, R McMillan.   

Abstract

The present studies provide direct evidence that some patients with chronic immune thrombocytopenic purpura (ITP) have autoantibodies reactive with platelet glycoprotein Ib ( GPIb ). Microtiter wells coated with a monoclonal antibody that recognized GPIb were reacted with either platelet extract or a control cell extract. After washing and incubating with test plasma, well-bound IgG was quantitated using radioactive anti-IgG. When compared to plasma from normal subjects, plasma from 3 of 106 patients with chronic ITP had significantly increased quantities of IgG bound to microtiter wells reacted with platelet extracts. Negative results were obtained with the remaining 103 patients with chronic ITP and 59 patients with a variety of other platelet disorders. Plasma from two of the three positive patients precipitated a protein from 125I-surface-labeled platelet extract with a molecular weight similar to GPlb . One of the three patients with anti- GPlb antibody also had demonstrable autoantibodies to the platelet glycoprotein llb / llla complex.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234034

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Antiplatelet autoantibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpura.

Authors:  S Nomura; M Yanabu; H Kido; T Fukuroi; K Yamaguchi; T Soga; H Nagata; T Kokawa; K Yasunaga
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

2.  Recent trends in platelet antigen/antibody detection.

Authors:  C Mueller-Eckhardt; V Kiefel; S Santoso
Journal:  Blut       Date:  1989-07

3.  Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura.

Authors:  S Nomura; M Yanabu; T Fukuroi; H Kido; T Kawakatsu; K Yamaguchi; M Suzuki; T Kokawa; K Yasunaga
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

4.  GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia.

Authors:  M A Nardi; L X Liu; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  Relationship of microparticles with beta 2-glycoprotein I and P-selectin positivity to anticardiolipin antibodies in immune thrombocytopenic purpura.

Authors:  S Nomura; M Yanabu; T Miyake; Y Miyazaki; H Kido; H Kagawa; S Fukuhara; Y Komiyama; E Matsuura; T Koike
Journal:  Ann Hematol       Date:  1995-01       Impact factor: 3.673

Review 6.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

7.  Laboratory investigation of immune thrombocytopenia.

Authors:  M Warner; J G Kelton
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

Review 8.  How do we diagnose immune thrombocytopenia in 2018?

Authors:  John G Kelton; John R Vrbensky; Donald M Arnold
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

9.  Autoantibodies in chronic ITP.

Authors:  P Tani; P Berchtold; R McMillan
Journal:  Blut       Date:  1989-07

10.  Laboratory workshop on the characterization of anti-platelet antibodies in immune thrombocytopenic purpura.

Authors:  H Gerber; P J Späth; B A Perret; J J Burckhardt
Journal:  Blut       Date:  1989-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.